News

Novo Nordisk shares plunge 24% after CagriSema obesity drug trial results

Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 24% at one point on Friday after reporting trial results that missed expectations.

adminadmin
Dec 20, 2024 - 19:00
 0  0
Novo Nordisk shares plunge 24% after CagriSema obesity drug trial results
Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 24% at one point on Friday after reporting trial results that missed expectations.
Read More

Tags:

Previous Article

Tesla shares drop 5%, continuing to slide as post-election rally loses steam

Next Article

Stock futures fall, Dow heads for worst week since 2023 as key inflation reading...

admin
admin

Related Posts

$103,500 reward offered after protected Mexican wolf's death in Arizona

$103,500 reward offered after protected Mexican wolf's...

admin Nov 18, 2024  0  1

IAC exploring spinoff of home improvement marketplace Angi

IAC exploring spinoff of home improvement marketplace Angi

admin Nov 12, 2024  0  1

The USWNT won Olympic gold. Why did none of their players make the Fifpro XI?

The USWNT won Olympic gold. Why did none of their players...

admin Dec 13, 2024  0  1